{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T04:26:21Z","timestamp":1781411181628,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.hfc.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T14:40:46Z","timestamp":1220020846000},"page":"455-464","source":"Crossref","is-referenced-by-count":3,"title":["Hyperkalemia Risk and Treatment of Heart Failure"],"prefix":"10.1016","volume":"4","author":[{"given":"Julian","family":"Segura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2008.03.009_bib1","unstructured":"US Department of Health and Human Services. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical Practice Guidelines No. 11, AHCPR publication No. 94-0612, June 1994."},{"issue":"Suppl","key":"10.1016\/j.hfc.2008.03.009_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/hrt.72.2_Suppl.S3","article-title":"Changing epidemiological features of cardiac failure","volume":"72","author":"Kannel","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.hfc.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1056\/NEJM199608153350707","article-title":"The management of chronic heart failure","volume":"335","author":"Cohn","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1527-5299.2004.02814.x","article-title":"Pharmacotherapy in congestive heart therapy: aldosterone receptor antagonism: interface with hyperkalemia in heart failure","volume":"10","author":"Sica","year":"2004","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.hfc.2008.03.009_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.1984.229","article-title":"Association between blood pressure and the rate of decline in renal function with age","volume":"26","author":"Lindeman","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.hfc.2008.03.009_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.23.1.3","article-title":"Are renal hemodynamics a key factor in the development and maintenance of essential hypertension?","volume":"23","author":"Ruilope","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2007.02.047","article-title":"Effect of first myocardial ischemic event on renal function","volume":"100","author":"Eijkelkamp","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2008.03.009_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/01.ASN.0000067420.83632.C1","article-title":"The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease","volume":"14","author":"Muntner","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.hfc.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9149(92)91194-9","article-title":"Renal function in severe congestive heart failure during treatment with enalapril","volume":"70","author":"Ljungman","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2008.03.009_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohumoral activation and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"issue":"Suppl I","key":"10.1016\/j.hfc.2008.03.009_bib11","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00004872-199611000-00001","article-title":"Blood pressure and renal function: therapeutic implications","volume":"14","author":"Ruilope","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) Study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.hfc.2008.03.009_bib14","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.hfc.2008.03.009_bib15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/00004872-200018110-00003","article-title":"Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure","volume":"18","author":"Ruilope","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archinte.1977.03630190010005","article-title":"Nonuremic diabetic hyperkalemia: possible role of insulin deficiency","volume":"137","author":"DeFronzo","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diabetes.32.11.1028","article-title":"Impairment of insulin-mediated glucose metabolism by hyperosmolarity in man","volume":"32","author":"Bratusch-Marrain","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.hfc.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM198002213020803","article-title":"Adrenergic modulation of extrarenal potassium disposal","volume":"302","author":"Rosa","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(12)80080-1","article-title":"A patient with hyperkalemia and metabolic acidosis","volume":"15","author":"Kurtzman","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hfc.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ki.1988.189","article-title":"Regulation of glomerular filtration rate in chronic congestive heart failure patients","volume":"34","author":"Cody","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.hfc.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9149(02)02581-X","article-title":"Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease","volume":"90","author":"Obialo","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01061372","article-title":"Drug attributed alterations in potassium handling in congestive cardiac failure","volume":"23","author":"Lawson","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hfc.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1523-1755.2000.00381.x","article-title":"ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure","volume":"58","author":"Bakris","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.hfc.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ahj.2006.05.030","article-title":"Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials","volume":"152","author":"de Denus","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function treated with an ACE inhibitor: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.03.009_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function and intolerant to ACE inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.03.009_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left ventricular systolic function: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.03.009_bib34","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2007.07.067","article-title":"Incidence and predictors of hyperkalemia in patients with heart failure","volume":"50","author":"Desai","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.03.009_bib35","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/archinte.167.18.1930","article-title":"Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction","volume":"167","author":"Phillips","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib36","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib37","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.03.009_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.03.009_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1527-5299.2001.00239.x","article-title":"Hyperkalemia in congestive heart failure","volume":"7","author":"Gehr","year":"2001","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.hfc.2008.03.009_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure","volume":"46","author":"Shah","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.03.009_bib44","first-page":"315","article-title":"Elderly heart failure patients with drug-induced serious hyperkalemia","volume":"12","author":"Vanpee","year":"2000","journal-title":"Aging"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713608000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713608000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T19:04:12Z","timestamp":1631732652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713608000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1551713608000536"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2008.03.009","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}